Serum CCL23 levels are increased in patients with systemic sclerosis

Archives of Dermatological Research

Volumn 303, Issue 1, 2011, Pages 29-34

  Yanaba, Koichi ^a   Yoshizaki, Ayumi ^b   Muroi, Eiji ^b   Ogawa, Fumihide ^b   Asano, Yoshihide ^c   Kadono, Takafumi ^c   Sato, Shinichi ^c  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

CCL23; Chemokine; ELISA; Systemic sclerosis

Indexed keywords

CHEMOKINE; CHEMOKINE CCL23; CHEMOKINE RECEPTOR CCR1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DERMATOMYOSITIS; DISEASE DURATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHEMOKINES, CC; DERMATOMYOSITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; HYPERTENSION, PULMONARY; JAPAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 79951721964     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-010-1078-8     Document Type: Article

References (27)

1. RD Berahovich Z Miao Y Wang B Premack MC Howard TJ Schall 2005 Proteolytic activation of alternative CCR1 ligands in inflammation J Immunol 174 7341 7351 1:CAS:528:DC%2BD2MXkt1Olsrc%3D 15905581 (Pubitemid 40705704)
2. A Bohan JB Peter 1975 Polymyositis and dermatomyositis (first of two parts) N Engl J Med 292 344 348 1:STN:280:DyaE2M7hvVyrtA%3D%3D 10.1056/NEJM197502132920706 1090839
3. PJ Clements PA Lachenbruch JR Seibold, et al. 1993 Skin thickness score in systemic sclerosis: an assessment of interobeservar variability in 3 independent studies J Rheumatol 20 1892 1896 1:STN:280:DyaK2c7ktFOqsw%3D%3D 8308774 (Pubitemid 24031593)
4. G Famularo A Procopio R Giacomelli, et al. 1990 Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis Clin Exp Immunol 81 368 372 1:CAS:528:DyaK3cXlslSitro%3D 10.1111/j.1365-2249.1990.tb05340.x 2397608 (Pubitemid 20273657)
5. R Fleischmajer JS Perlish JRT Reeves 1977 Cellular infiltrates in scleroderma skin Arthritis Rheum 20 975 984 1:STN:280:DyaE2s7otFKnsw%3D%3D 10.1002/art.1780200410 861067
6. A Grassegger G Schuler G Hessenberger, et al. 1998 Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial Br J Dermatol 139 639 648 1:CAS:528:DyaK1cXntlCktb4%3D 10.1046/j.1365-2133.1998. 02460.x 9892907 (Pubitemid 28474310)
7. KY Han CW Kim TH Lee Y Son J Kim 2009 CCL23 up-regulates expression of KDR/Flk-1 and potentiates VEGF-induced proliferation and migration of human endothelial cells Biochem Biophys Res Commun 382 124 128 1:CAS:528: DC%2BD1MXktF2ntrw%3D 10.1016/j.bbrc.2009.02.149 19265684
8. M Hasegawa M Fujimoto K Kikuchi K Takehara 1997 Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis J Rheumatol 24 328 332 1:STN:280:DyaK2s7oslGguw%3D%3D 9034992 (Pubitemid 27104098)
9. J Hwang KN Son CW Kim, et al. 2005 Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis Cytokine 30 254 263 1:CAS:528:DC%2BD2MXltFWlsLc%3D 10.1016/j.cyto.2005.01.018 15927850 (Pubitemid 40775844)
10. EC LeRoy T Krieg C Black, et al. 1988 Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis J Rheumatol 15 202 205 1:STN:280:DyaL1c3gtVWnsg%3D%3D 3361530 (Pubitemid 18073738)
11. T Matsushita M Hasegawa Y Hamaguchi K Takehara S Sato 2006 Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis J Rheumatol 33 275 284 1:CAS:528:DC%2BD28XhvFOnt78%3D 16465658 (Pubitemid 43209303)
12. M Molteni S Della Bella B Mascagni, et al. 1999 Increased interferon-gamma (IFN-γ) levels produced in vitro by alloactivated T lymphocytes in systemic sclerosis and Raynaud's phenomenon Clin Exp Immunol 116 164 168 1:CAS:528:DyaK1MXis1Cntrg%3D 10.1046/j.1365-2249.1999.00842.x 10209521 (Pubitemid 29170020)
13. B Nardelli DK Morahan GW Bong MA Semenuk BL Kreider G Garotta 1999 Dendritic cells and MPIF-1: chemotactic activity and inhibition of endogenous chemokine production by IFN-gamma and CD40 ligation J Leukoc Biol 65 822 828 1:CAS:528:DyaK1MXktVCitr0%3D 10380905 (Pubitemid 29279532)
14. B Nardelli HL Tiffany GW Bong, et al. 1999 Characterization of the signal transduction pathway activated in human monocytes and dendritic cells by MPIF-1, a specific ligand for CC chemokine receptor 1 J Immunol 162 435 444 1:CAS:528:DyaK1MXjt12qsg%3D%3D 9886417 (Pubitemid 29018951)
15. BW Needleman FM Wigley RW Stair 1992 Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor-α, and interferon-γ levels in sera from patients with scleroderma Arthritis Rheum 35 67 72 1:STN:280:DyaK387hvVWnsw%3D%3D 10.1002/art.1780350111 1731816
16. H Novak A Muller N Harrer C Gunther JM Carballido M Woisetschlager 2007 CCL23 expression is induced by IL-4 in a STAT6-dependent fashion J Immunol 178 4335 4341 1:CAS:528:DC%2BD2sXjt1Wlu70%3D 17371990 (Pubitemid 46492384)
17. I Rioja FJ Hughes CH Sharp, et al. 2008 Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor Arthritis Rheum 58 2257 2267 1:CAS:528:DC%2BD1cXhtVCjtbbJ 10.1002/art.23667 18668547
18. AD Roumm TL Whiteside TA Medsger Jr GP Rodnan 1984 Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations Arthritis Rheum 27 645 653 1:STN:280: DyaL2c3jtFGmuw%3D%3D 10.1002/art.1780270607 6375682 (Pubitemid 14089474)
19. S Sato H Ihn K Kikuchi K Takehara 1994 Antihistone antibodies in systemic sclerosis: association with pulmonary fibrosis Arthritis Rheum 37 391 394 1:STN:280:DyaK2c7nsF2rug%3D%3D 10.1002/art.1780370313 8129794 (Pubitemid 24093631)
20. K Scharffetter B Lankat-Buttgereit T Krieg 1988 Localization of collagen mRNA in normal and scleroderma skin by in situ hybridization Eur J Clin Invest 18 9 17 1:CAS:528:DyaL1cXhsVyhu70%3D 10.1111/j.1365-2362.1988.tb01158.x 3130266
21. KN Son J Hwang BS Kwon J Kim 2005 Human CC chemokine CCL23 enhances expression of matrix metalloproteinase-2 and invasion of vascular endothelial cells Biochem Biophys Res Commun 340 498 504 10.1016/j.bbrc.2005.12.037 16378600
22. VD Steen TA Medsger Jr 2000 Severe organ involvement in systemic sclerosis with diffuse scleroderma Arthritis Rheum 43 2437 2444 1:STN:280:DC%2BD3M%2FktFequw%3D%3D 10.1002/1529-0131(200011)43:11<2437::AID- ANR10>3.0.CO;2-U 11083266
23. VD Steen DL Powell TAJ Medsger 1988 Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis Arthritis Rheum 31 196 203 1:STN:280:DyaL1c7mt12nsQ%3D%3D 10.1002/art.1780310207 3348823 (Pubitemid 18088039)
24. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
25. EM Tan AS Cohen JF Fries, et al. 1982 The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 25 1271 1277 1:STN:280:DyaL3s%2FkvVCmtA%3D%3D 10.1002/art.1780251101 7138600 (Pubitemid 13221242)
26. G Valentini A Della Rossa S Bombardieri, et al. 2001 European multicentre study to define disease activity criteria for systemic sclerosis II. Identification of disease activity variables and development of preliminary activity indexes Ann Rheum Dis 60 592 598 1:STN:280:DC%2BD3M3lt1WqsQ%3D%3D 10.1136/ard.60.6.592 11350848 (Pubitemid 32493986)
27. B White 1996 Immunopathogenesis of systemic sclerosis Rheum Dis Clin North Am 32 695 708 10.1016/S0889-857X(05)70296-9 (Pubitemid 26396046)